Sirona Medical partners with RevealDx to transform lung cancer screening with a comprehensive suite of reimbursed AI tools

Sirona leads a set of clinically-validated capabilities that amplifies the efficiency and precision of lung nodule assessment, improving diagnostic quality for the leading cause of cancer-related death in the United States.

SAN FRANCISCO, Nov. 17, 2022 /PRNewswire/ — Sirona Medical, the leader in cloud-native radiology workflow software, today announced a comprehensive distribution and collaboration partnership with RevealDX and the integration of Nines’ FDA-cleared automated measurement tool recently acquired by Sirona to improve end to end care for patients with lung nodules.

Read the full press release here.